Over 1 Year Ago
1 Min Read

TXG shares ran down -8% today. A closer look at the stock:



10X Genomics Inc (TXG) is trading -8% lower at $39.58 today. While it's a gloomy day for the Health Care sector in general, the stock is lagging behind it's peers.

  • Goldman Sachs downgraded the life sciences company to Sell from Neutral
  • Cited significantly slower revenue trajectory  

The share price is likely moving as a result of the recent earnings call on August 08.

10X Genomics Inc has been trading between a 52-week high of $191.15 and a 52-week low of $33.3. The stock has a market cap of $3.76 Billion.

10x Genomics is an American biotechnology company that designs and manufactures gene sequencing technology used in scientific research. It was founded in 2012 by Serge Saxonov, Ben Hindson, and Kevin Ness.

Headlines


Bear Market Strikes Back: Analysts Upgrade or Downgrade Bed Bath & Beyond, Verizon and More
24/7 Wall street 08-18-22

10x Genomics Inc. (NASDAQ: TXG) Shares Fall By -8.63 Percent In The Past Week, But How Long Will It Last?
Marketing Sentinel 08-18-22

Goldman Sachs Downgrades 10X Genomics to Sell
Investing.com 08-18-22

10x Genomics Return On Capital Employed Overview
Benzinga 08-12-22

10X Genomics PT Lowered to $65 at Stifel
Investing.com 08-09-22